Organovo Holdings Company

Organovo develops a range of tissue and disease models for medical research and therapeutic applications.

Estimated Revenue: $1M to $10M
Headquarters: San Diego, California, United States
Employee Number: 51-100
Investors Number: 2
Funding Status: IPO
Total Funding: $117.4M
Industry: PharmTech
Technology: Others
Last Funding Type: Series E
Founded Date: 2007